Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,756Revenue $M4.8Net Margin (%)-5,332.3Z-Score-3.6
Enterprise Value $M2,198EPS $-1.7Operating Margin %-6,138.1F-Score2
P/E(ttm))0Cash Flow Per Share $-1.3Pre-tax Margin (%)-6,797.1Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %-21.7Quick Ratio7.6Cash flow > EarningsY
Price/Sales3815-y EBITDA Growth Rate %-21.0Current Ratio7.6Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-32.5Higher Current Ratio y-yN
Dividend Yield %3.3Insider Buy (3m)1ROE % (ttm)-197.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M115ROI % (ttm)-32.8Gross Margin Increase y-yN

Gurus Latest Trades with THRX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
THRXRichard Perry 2014-09-30 Add0.19%$17.53 - $30.4
($22.87)
$ 15.22-33%Add 20.69%1,831,099
THRXSeth Klarman 2014-09-30 Reduce-0.28%$17.53 - $30.4
($22.87)
$ 15.22-33%Reduce -2.84%19,815,983
THRXRichard Perry 2014-06-30 Buy 1.2%$21.154 - $30.1
($23.88)
$ 15.22-36%New holding, 1517208 sh.1,517,208
THRXSeth Klarman 2014-06-30 Reduce-0.23%$21.154 - $30.1
($23.88)
$ 15.22-36%Reduce -1.5%20,395,056
THRXSeth Klarman 2014-03-31 Add0.42%$24.31 - $32.63
($29.32)
$ 15.22-48%Add 2.79%20,705,801
THRXSeth Klarman 2013-12-31 Add1.65%$27.19 - $32.81
($29.19)
$ 15.22-48%Add 8.83%20,144,301
THRXJean-Marie Eveillard 2013-12-31 Add0.03%$27.19 - $32.81
($29.19)
$ 15.22-48%Add 23.4%1,509,404
THRXSeth Klarman 2013-09-30 Add2.3%$28.86 - $34.36
($31.06)
$ 15.22-51%Add 11.92%18,510,371
THRXSeth Klarman 2013-06-30 Add2.85%$18.15 - $33.74
($26.83)
$ 15.22-43%Add 22.02%16,538,977
THRXJean-Marie Eveillard 2013-06-30 Add0.08%$18.15 - $33.74
($26.83)
$ 15.22-43%Add 139.14%1,109,620
THRXJean-Marie Eveillard 2012-06-30 Add0.01%$14.11 - $19.04
($16.72)
$ 15.22-9%Add 24.23%509,710
THRXSeth Klarman 2012-03-31 Add0.22%$13.21 - $16.28
($13.91)
$ 15.229%Add 2.3%14,553,800
THRXJean-Marie Eveillard 2012-03-31 Add0.01%$13.21 - $16.28
($13.91)
$ 15.229%Add 25.59%410,310
THRXSeth Klarman 2011-09-30 Add0.84%$14.05 - $20.04
($16.74)
$ 15.22-9%Add 9.76%14,225,961
THRXJulian Robertson 2011-09-30 Sold Out -1.2512%$14.05 - $20.04
($16.74)
$ 15.22-9%Sold Out0
THRXJohn Griffin 2011-06-30 Sold Out $17.07 - $23.13
($20)
$ 15.22-24%Sold Out0
THRXJean-Marie Eveillard 2011-06-30 Reduce-0.02%$17.07 - $23.13
($20)
$ 15.22-24%Reduce -33.79%326,710
THRXJean-Marie Eveillard 2011-03-31 Add0.02%$16.91 - $20.77
($18.79)
$ 15.22-19%Add 51.02%493,410
THRXWilbur Ross 2011-03-31 Sold Out $16.91 - $20.77
($18.79)
$ 15.22-19%Sold Out0
THRXDavid Swensen 2011-03-31 Sold Out -6.58%$16.91 - $20.77
($18.79)
$ 15.22-19%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

THRX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
THRX Richard Perry 2014-09-301,831,0991.591.1+20.69%
THRX Jean-Marie Eveillard 2014-09-301,593,6201.380.07-0.12%
THRX Seth Klarman 2014-09-3019,815,98317.185.9-2.84%
Premium Most recent portfolio changes are included for Premium Members only!


THRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLC10% Owner 2014-11-04Buy832,456$12786500-100view
LEE JUNNINGSr. VP, Technical Operations 2014-08-13Sell53,424$22.5-32.36view
Shafer Bradford JSr VP, Gen. Counsel, Secretary 2014-08-12Sell28,156$22.13-31.22view
GLAXOSMITHKLINE PLC10% Owner 2014-08-11Buy172,651$3912270-100view
GLAXOSMITHKLINE PLC10% Owner 2014-05-09Buy317,770$8544840-100view
Shafer Bradford JSr VP, Gen. Counsel, Secretary 2014-03-03Sell65,806$36.73-58.56view
Mammen MathaiSVP, Research & Early Clin Dev 2014-02-14Sell35,000$39.36-61.33view
GLAXOSMITHKLINE PLC10% Owner 2014-02-11Buy342,229$12850700-100view
GLAXOSMITHKLINE PLC10% Owner 2013-10-29Buy130,473$4913610-100view
Winningham Rick ECEO 2013-09-12Sell22,353$40.03-61.98view

Press Releases about THRX :

    Quarterly/Annual Reports about THRX:

    News about THRX:

    Articles On GuruFocus.com
    Seth Klarman Keeps Buying LNG, KERX, PBF And Keeps Selling THRX Dec 05 2014 
    Data Published on Anoro(R) Ellipta(R) Demonstrate Improved Lung Function Compared to Tiotropium Oct 17 2014 
    Theravance, Inc. Appoints Eric d'Esparbes as Senior Vice President and Chief Financial Officer Oct 15 2014 
    Seth Klarman Buys Cheniere Energy, Keryx Biopharmaceuticals, Idenix Pharmaceuticals, Sells BP, Fidel May 15 2014 
    Seth Klarman Buys Micron Technology, Theravance, PBF Energy, Sells BP, AIG, Yamana Gold Nov 13 2013 
    Seth Klarman's Top 5 Second Quarter Holdings Aug 14 2013 
    Top Four from Baupost’s Seth Klarman Jul 18 2013 
    What Can We Earn If We Invest in the Top Five Holdings of the Baupost Group? May 29 2013 
    Weekly CEO Sells Highlight: Texas Roadhouse Inc., Theravance Inc., AmerisourceBergen Corp. and Nuanc May 06 2013 
    WEEKLY CFO SELLS HIGHLIGHT: THRX, BERY, IPG, PG, ZNGA, TSS May 05 2013 

    More From Other Websites
    REMINDER: Theravance Biopharma to Host Investor and Analyst Day on December 12th Dec 09 2014
    Theravance Biopharma Announces New Employment Inducement Awards Dec 03 2014
    THERAVANCE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 01 2014
    THERAVANCE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 19 2014
    THERAVANCE INC Financials Nov 14 2014
    THERAVANCE INC Files SEC form 8-K, Regulation FD Disclosure Nov 13 2014
    Theravance Biopharma to Present at the Stifel Healthcare Conference on November 18th Nov 12 2014
    Theravance Biopharma Q3 Loss Widens Y/Y, Revenues Beat Nov 10 2014
    10-Q for Theravance, Inc. Nov 06 2014
    Theravance Biopharma, Inc. Reports Third Quarter 2014 Financial Results Nov 06 2014
    Theravance to Present at Two Upcoming Investor Conferences in November Nov 05 2014
    THERAVANCE INC Files SEC form 10-Q, Quarterly Report Nov 04 2014
    Theravance (THRX) Falls on Wider-than-Expected Loss in Q3 Nov 03 2014
    Theravance misses Street 3Q forecasts Oct 31 2014
    Theravance misses Street 3Q forecasts Oct 31 2014
    Theravance Biopharma, Inc. to Report Third Quarter 2014 Financial Results on November 6, 2014 Oct 30 2014
    THERAVANCE INC Files SEC form 8-K, Results of Operations and Financial Condition Oct 30 2014
    Theravance Reports Third Quarter 2014 Financial Results Oct 30 2014
    Q3 2014 Theravance Inc Earnings Release - After Market Close Oct 30 2014
    THERAVANCE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Oct 28 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK